Participants

Type 2 Diabetes

A randomized, double-blind, parallel-group, multicenter study to evaluate the glycemic effects, safety, and tolerability of Metformin Delayed-Release in subjects with Type 2 Diabetes.

Fibromyalgia

Low Back Pain

Insomnia

Healthy Volunteers

Schizophrenia

with alcohol abuse disorder

This double-blind, randomized study will evaluate the efficacy, safety and tolerability of ALKS 3831 in subjects with schizophrenia and alcohol use disorder (AUD). To qualify you must have experienced an acute exacerbation of schizophrenia within the past 6 months, have a diagnosis of schizophrenia and alcohol use disorder, and be 18 or older. Compensation for time and travel may be available.

Smoking Cessasion

A Multi-Center, multi-Region Smoking Cessation study to understand the biological and functional changes related to Smoking Cessation in healthy smokers who are continuously abstinent from smoking for one year